Involvement of wee1 in the circadian rhythm-dependent intestinal damage induced by docetaxel

Journal of Pharmacology and Experimental Therapeutics

Volumn 347, Issue 1, 2013, Pages 242-248

  Obi Ioka, Yuri ^a   Ushijima, Kentaro ^a   Kusama, Mikio ^a   Ishikawa Kobayashi, Eiko ^a   Fujimura, Akio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYCLIN DEPENDENT KINASE 1; DOCETAXEL; MESSENGER RNA; PROTEIN BMAL1; REGULATOR PROTEIN; SURVIVIN; TRANSCRIPTION FACTOR CLOCK; UNCLASSIFIED DRUG; WEE1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BMAL1 GENE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BLOOD LEVEL; E BOX ELEMENT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME MODIFICATION; FEMALE; GENE EXPRESSION; INTESTINE INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATOR GENE; WEE1 GENE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE PROTEINS; CIRCADIAN RHYTHM; DOSE-RESPONSE RELATIONSHIP, DRUG; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MICE; MICE, INBRED BALB C; NUCLEAR PROTEINS; PROTEIN-TYROSINE KINASES; TAXOIDS;

EID: 84884633454     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.113.203299     Document Type: Article

References (27)

1. Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, and Kroemer G (2004) Cell death by mitotic catastrophe: a molecular definition. Oncogene 23:2825-2837.
2. Chen Y, Tsai YH, and Tseng SH (2013) Inhibition of cyclin-dependent kinase 1-induced cell death in neuroblastoma cells through the microRNA-34a-MYCNsurvivin pathway. Surgery 153:4-16.
3. Chow JPH and Poon RYC (2012) The CDK1 inhibitory kinase MYT1 in DNA damage checkpoint recovery. Oncogene DOI: 10.1038/onc.2012.504 [Epub].
4. Fabbri F, Amadori D, Carloni S, Brigliadori G, Tesei A, Ulivi P, Rosetti M, Vannini I, Arienti C, and Zoli W, et al. (2008) Mitotic catastrophe and apoptosis induced by docetaxel in hormone-refractory prostate cancer cells. J Cell Physiol 217: 494-501.
5. Gérard C and Goldbeter A (2012) Entrainment of the mammalian cell cycle by the circadian clock: modeling two coupled cellular rhythms. PLOS Comput Biol 8: e1002516.
6. Ibrahim NK, Sahin AA, Dubrow RA, Lynch PM, Boehnke-Michaud L, Valero V, Buzdar AU, and Hortobagyi GN (2000) Colitis associated with docetaxelbased chemotherapy in patients with metastatic breast cancer. Lancet 355: 281-283.
7. Ijiri K and Potten CS (1983) Response of intestinal cells of differing topographical and hierarchical status to ten cytotoxic drugs and five sources of radiation. Br J Cancer 47:175-185.
8. Innominato PF, Lévi FA, and Bjarnason GA (2010) Chronotherapy and the molecular clock: Clinical implications in oncology. Adv Drug Deliv Rev 62:979-1001.
9. Jones MK, Padilla OR, and Zhu E (2010) Survivin is a key factor in the differential susceptibility of gastric endothelial and epithelial cells to alcohol-induced injury. J Physiol Pharmacol 61:253-264.
10. Lamers F, van der Ploeg I, Schild L, Ebus ME, Koster J, Hansen BR, Koch T, Versteeg R, Caron HN, and Molenaar JJ (2011) Knockdown of survivin (BIRC5) causes apoptosis in neuroblastoma via mitotic catastrophe. Endocr Relat Cancer 18: 657-668.
11. Lemmer B (2000) Relevance for chronopharmacology in practical medicine. Semin Perinatol 24:280-290.
12. Livak KJ and Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
13. Magnussen GI, Holm R, Emilsen E, Rosnes AKR, Slipicevic A, and Flørenes VA (2012) High expression of Wee1 is associated with poor disease-free survival in malignant melanoma: potential for targeted therapy. PLoS ONE 7:e38254.
14. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, and Okamura H (2003) Control mechanism of the circadian clock for timing of cell division in vivo. Science 302: 255-259.
15. Mhaidat NM, Wang Y, Kiejda KA, Zhang XD, and Hersey P (2007) Docetaxel-induced apoptosis in melanoma cells is dependent on activation of caspase-2. Mol Cancer Ther 6:752-761.
16. Mohawk JA, Green CB, and Takahashi JS (2012) Central and peripheral circadian clocks in mammals. Annu Rev Neurosci 35:445-462.
17. Montero A, Fossella F, Hortobagyi G, and Valero V (2005) Docetaxel for treatment of solid tumours: a systematic review of clinical data. Lancet Oncol 6:229-239.
18. Morse DL, Gray H, Payne CM, and Gillies RJ (2005) Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells. Mol Cancer Ther 4: 1495-1504.
19. Noda T, Iwakiri R, Fujimoto K, Matsuo S, and Aw TY (1998) Programmed cell death induced by ischemia-reperfusion in rat intestinal mucosa. Am J Physiol 274: G270-G276.
20. Pellegrini F and Budman DR (2005) Review: tubulin function, action of antitubulin drugs, and new drug development. Cancer Invest 23:264-273.
21. Polidarová L, Soták M, Sládek M, Pacha J, and Sumová A (2009) Temporal gradient in the clock gene and cell-cycle checkpoint kinase Wee1 expression along the gut. Chronobiol Int 26:607-620.
22. Roninson IB, Broude EV, and Chang BD (2001) If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat 4:303-313.
23. Rubio N, Garcia-Segura LM, and Arevalo MA (2012) Survivin prevents apoptosis by binding to caspase-3 in astrocytes infected with the BeAn strain of Theiler's murine encephalomyelitis virus. J Neurovirol 18:354-363.
24. Tampellini M, Filipski E, Liu XH, Lemaigre G, Li XM, Vrignaud P, François E, Bissery MC, and Lévi F (1998) Docetaxel chronopharmacology in mice. Cancer Res 58:3896-3904.
25. Vakifahmetoglu H, Olsson M, and Zhivotovsky B (2008) Death through a tragedy: mitotic catastrophe. Cell Death Differ 15:1153-1162.
26. Ye QF, Zhang YC, Peng XQ, Long Z, Ming YZ, and He LY (2012) Silencing Notch-1 induces apoptosis and increases the chemosensitivity of prostate cancer cells to docetaxel through Bcl-2 and Bax. Oncol Lett 3:879-884.
27. Vergniol JC, Bruno R, Montay G, and Frydman A (1992) Determination of Taxotere in human plasma by a semi-automated high-performance liquid chromatographic method. J Chromatogr A 582:273-278.